FDA: Avoid IBS Drug Viberzi in Patients With No Gallbladder FDA: Avoid IBS Drug Viberzi in Patients With No Gallbladder

Patients without a gallbladder have an increased risk for serious pancreatitis when taking eluxadoline.News Alerts
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news